Skip to content

Randomized Controlled Trial: Aprepitant plus Ondansetron to Prevent PONV after Thyroidectomy

Aprepitant Combined with Ondansetron for Preventing Postoperative Nausea and Vomiting after Thyroidectomy - A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600131893
Enrollment
Unknown
Registered
2026-09-07
Start date
2026-09-10
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PONV after thyroidectomy

Interventions

Group U:Aprepitant combined with ondansetron

Sponsors

The Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 to 65 years with ASA physical status ?–? who underwent elective thyroidectomy (including partial, subtotal and total thyroidectomy) under general anesthesia, volunteered to participate, and were accessible for postoperative follow-up and assessment;

Exclusion criteria

Exclusion criteria: 1.Patients with uncontrolled severe underlying diseases; 2.patients with a history of PONV or motion sickness, or preoperative nausea and vomiting; 3.patients allergic to study drugs or their excipients; 4.patients receiving glucocorticoids, 5-HT3 receptor antagonists, NK-1 receptor antagonists, anticholinergics, antihistamines or other known antiemetic medications within one week before surgery; 5.pregnant or lactating women; 6.patients with poor compliance unable to complete follow-up; 7.and other conditions deemed ineligible by researchers.

Design outcomes

Primary

MeasureTime frame
Incidence of PONV within 24 hours after surgery;Proportion of patients with nausea, vomiting or retching meeting diagnostic criteria;

Secondary

MeasureTime frame
Adverse drug reactions;Severity of PONV;Antiemetic efficacy rate;

Countries

China

Contacts

Public ContactYing Zhao

The Second People's Hospital

zhao.ying-2001@163.com+86 553 3909017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026